Insider trades
Michael Landsittel, Director of Damora Therapeutics DMRA, has filed 0 purchases and 15 sales on the open market. The latest trade was on 03/23.
Michael Landsittel
Director
- Company
- Damora Therapeutics DMRA
- First filing
- 23/03/03
- Trades
- 44 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- No record
- Last trade
- 03/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/03/05 | 25/03/07 | 5,284 sh | $88.80 | $469,219.2 | −6.8% | |
| Open-market sale10b5-1 plan | 24/08/15 | 24/08/19 | 4,409 sh | $95.23 | $419,869.07 | −6.2% | |
| Open-market sale10b5-1 plan | 24/05/15 | 24/05/17 | 3,850 sh2 trades | $106.95avg. | $411,772.46 | −5.1% | |
| Open-market sale10b5-1 plan | 24/05/02 | 24/05/06 | 10,000 sh | $105.00 | $1,050,000 | −17.5% | |
| Open-market sale10b5-1 plan | 24/03/28 | 24/04/01 | 5,000 sh | $95.00 | $475,000 | −9.6% | |
| Open-market sale10b5-1 plan | 24/03/15 | 24/03/19 | 13,734 sh6 trades | $87.78avg. | $1,205,606.2 | −22.5% | |
| Open-market sale | 24/03/07 | 24/03/11 | 5,003 sh | $90.69 | $453,722.07 | −8.2% | |
| Open-market sale | 23/03/06 | 23/03/08 | 3,007 sh2 trades | $45.68avg. | $137,361 | −5.8% |